Vitamin D Products

(off-site)

Donate via PayPal

Your tax-deductable gift will help us to be more effective in our mission to end the worldwide epidemic of vitamin D deficiency.

Vitamin D On The Web

See our Vitamin D News page for all the latest vitamin D headlines from around the globe.

Our Best Vitamin D Articles page for links to informative, less-mainstream articles on vitamin D and UV exposure.

Vitamin D Research

back to research menu

Osteopenia

Low patient compliance—a major negative factor in achieving vitamin D adequacy in elderly hip fracture patients supplemented with 800IU of vitamin D3 daily. Arch Gerontol Geriatr. 2009 Nov–Dec;49(3):364–7.
Evidence of association of Vitamin D receptor Apa I gene polymorphism with bone mineral density in postmenopausal women with osteoporosis. Clin Rheumatol. 2009 Oct;28(10):1187–91.
Osteopenia in alcoholics: effect of alcohol abstinence. Alcohol Alcohol. 2009 Sep–Oct;44(5):468–75.
Risks of osteoporosis associated with breast cancer treatment: the need to access to preventive treatment. Maturitas. 2009 Sep 20;64(1):1–3.
Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values. BJU Int. 2009 Sep;104(6):800–5.
Update on cystic fibrosis-related bone disease: a special focus on children. Paediatr Respir Rev. 2009 Sep;10(3):134–42.
Secondary Causes of Low Bone Mass in Patients With Breast Cancer: A Need for Greater Vigilance. J Clin Oncol. 2009 Aug 1;27(22):3605–10.
Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug. Bone. 2009 Aug;45(2):232–7.
Metabolic Bone Disease in preterm newborn: an update on nutritional issues. Riv Ital Pediatr. 2009 Jul 14;35(1):20.
Osteoporosis in inflammatory bowel disease. Am J Med. 2009 Jul;122(7):599–604. Review.
A study of bone mineral density in adults with disability. Arch Phys Med Rehabil. 2009 Jul;90(7):1127–35.
Osteopenia and vitamin D deficiency in children with sickle cell disease. Arch Pediatr. 2009 Jun;16(6):619–21.
An observational study on the adherence to treatment guidelines of osteopenia. J Womens Health (Larchmt). 2009 Jun;18(6):873–81.
Osteoporosis in Parkinson's disease. Parkinsonism Relat Disord. 2009 Jun;15(5):339–46.
Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy. Ann Saudi Med. 2009 May–Jun;29(3):215–8.
The Evaluation of Secondary Causes of Bone Loss in a Primary Care Setting. Endocr Pract. 2009 May 6:1–16.
Approach to the patient with transplantation-related bone loss. J Clin Endocrinol Metab. 2009 May;94(5):1483–90.
Is there any requirement for celiac disease screening routinely in postmenapausal women with osteoporosis? Rheumatol Int. 2009 May;29(7):841–5.
Vitamin d. Int J Biochem Cell Biol. 2009 May;41(5):982–5.
Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis. 2009 Apr 30.
Diffuse osteopenia and myelopathy in a puppy fed a diet composed of an organic premix and raw ground beef. J Am Vet Med Assoc. 2009 Apr 15;234(8):1041–8.
Spine bone mineral density and VDR polymorphism in subjects with ulcerative colitis. J Bone Miner Metab. 2009 Apr 14.
Bone mineral density and secondary hyperparathyroidism in pulmonary hypertension. Open Respir Med J. 2009 Apr 14;3:53–60.
Treatment of osteoporosis/osteopenia in pediatric leukemia and lymphoma. Ann Pharmacother. 2009 Apr;43(4):714–20.
Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Gastroenterology. 2009 Apr;136(4):1317–27, e1–2.
Long-term effects of giving nursing home residents bread fortified with 125 microg (5000 IU) vitamin D(3) per daily serving. Am J Clin Nutr. 2009 Apr;89(4):1132–7.
Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients. Bone. 2009 Apr;44(4):678–83.
Platelet-rich plasma suppresses osteoclastogenesis by promoting the secretion of osteoprotegerin. J Periodontal Res. 2009 Apr;44(2):217–24.
Hip fractures in the elderly in Israel—possible impact of preventable conditions. Arch Gerontol Geriatr. 2009 Mar–Apr;48(2):182–5.
Behavioural and physical characteristics associated with vitamin D status in women. Bone. 2009 Mar 2.
Vitamin D metabolism and vitamin D traditional and nontraditional, target organs: implications for kidney patients. J Ren Care. 2009 Mar;35 Suppl 1:39–44.
Dietary reference intakes for vitamin D: justification for a review of the 1997 values. Am J Clin Nutr. 2009 Mar;89(3):719–27.
Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer. BJU Int. 2009 Mar;103(6):753–7.
High bone density in young Hutterite children. Bone. 2009 Mar;44(3):454–60.
Positive association between the course of vitamin D intake and bone mineral density at 36 years in men. Bone. 2009 Mar;44(3):437–41.
Absence of adynamic bone disease in African- Americans with CKD Stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio. Clin Nephrol. 2009 Mar;71(3):267–75.
Nutritional therapies (including fosteum). Curr Osteoporos Rep. 2009 Mar;7(1):5–11.
Age-related bone loss in the LOU/c rat model of healthy ageing. Exp Gerontol. 2009 Mar;44(3):183–9.
Effects of platelet-derived growth factor, vitamin D and parathyroid hormone on osteoblasts derived from cancer patients on chronic bisphosphonate therapy. Int J Mol Med. 2009 Mar;23(3):407–13.
What is next for the Dietary Reference Intakes for bone metabolism related nutrients beyond calcium: phosphorus, magnesium, vitamin D, and fluoride? Crit Rev Food Sci Nutr. 2009 Feb;49(2):136–44.
Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European country. BMC Public Health 2009 Jan 19, 9:22.
A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis. AIDS. 2009 Jan 2;23(1):51–7.
Rheumatic manifestations of renal disease. Curr Opin Rheumatol. 2009 Jan;21(1):55–61. Review.
Vitamin D: skeletal and extra skeletal effects; recommendations for good practice. Presse Med. 2009 Jan;38(1):43–54. Review in French.
Ultrasound bone mass in schizophrenic patients on antipsychotic therapy. Hum Psychopharmacol. 2009 Jan;24(1):49–54.
Vitamin D Status and its Relationship to Body Fat, Final Height, and Peak Bone Mass in Young Women. J Clin Endocrinol Metab. 2009 Jan;94(1):67–73.
Gene expression signatures of a fibroblastoid preosteoblast and cuboidal osteoblast cell model compared to the MLO-Y4 osteocyte cell model. Bone. 2009 Jan;44(1):32–45.
Rheumatic manifestations of renal disease. Curr Opin Rheumatol. 2009 Jan;21(1):55–61.
Bone Mineral Density and Vitamin D Status in Female and Male Patients with Osteoarthritis of the Knee or Hip. Eur Surg Res. 2009;42(1):1–10.
Vitamin D: current status and perspectives. Clin Chem Lab Med. 2008 Dec 22.
Geographic location and vitamin D synthesis. Mol Aspects Med. 2008 Dec;29(6):453–61.
Effect of Roux-en Y Gastric Bypass on Bone Metabolism in Patients with Morbid Obesity: Mansoura Experiences. Obes Surg. 2008 Dec;18(12):1526–31.
Closing the Gap: Bone Health Education in Orthopaedic Practice. Orthop Nurs. 2008 Nov–Dec;27(6):340–6; quiz 347–8.
Vitamin D: skeletal and extra skeletal effects; recommendations for good practice. Presse Med. 2008 Nov 10. In French.
Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant. 2008 Nov;23(11):3670–6.
Role of bone biopsy in stages 3 to 4 chronic kidney disease. Clin J Am Soc Nephrol. 2008 Nov;3 Suppl 3:S170–4.
Vitamin D and musculoskeletal health. Nat Clin Pract Rheumatol. 2008 Nov;4(11):580–8.
Prevalence of Secondary Causes of Bone Loss Among Breast Cancer Patients With Osteopenia and Osteoporosis. J Clin Oncol. 2008 Oct 27.
Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J Clin Oncol. 2008 Oct 20;26(30):4875–82.
Vitamin D Deficiency among HIV Type 1-Infected Individuals in the Netherlands: Effects of Antiretroviral Therapy. AIDS Research and Human Retroviruses. 2008 Oct. 18. Vol. 4 No. 11.
Bone metabolism in postmenopausal women with lumbar spinal stenosis: analysis of bone mineral density and bone turnover markers. Spine. 2008 Oct 15;33(22):2435–9.
Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer. Clin Cancer Res. 2008 Oct 1;14(19):6336–42.
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008 Oct;29(6):726–76. Review.
Perspectives on obesity and sweeteners, folic acid fortification and vitamin D requirements. Fam Pract. 2008 Sep 30.
Health maintenance for postmenopausal women. Am Fam Physician. 2008 Sep 1;78(5):583–91.
Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology (Oxford). 2008 Sep;47(9):1348–51.
Changes in bone turnover, bone mineral and fracture risk induced by drugs used to treat epilepsy. Curr Drug Saf. 2008 Sep;3(3):168–72. Review.
The vitamin D receptor Fok1 polymorphism and bone mineral density in Chinese children. Clin Chim Acta. 2008 Sep;395(1–2):111–4.
Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia: BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design. Contemp Clin Trials. 2008 Sep;29(5):711–9.
Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study. Osteoporos Int. 2008 Aug;19(8):1211–7.
High bone turnover but normal bone mineral density in women suffering from schizophrenia. Psychol Med. 2008 Aug;38(8):1195–201.
African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am J Clin Nutr. 2008 Aug;88(2):545S–550S. Review.
25-Hydroxyvitamin D: functional outcomes in infants and young children. Am J Clin Nutr. 2008 Aug;88(2):529S–533S. Review.
Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr. 2008 Aug;88(2):513S–519S. Review.
Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone. 2008 Jul;43(1):149–55.
Protein-containing nutrient supplementation following strength training enhances the effect on muscle mass, strength, and bone formation in postmenopausal women. J Appl Physiol. 2008 Jul;105(1):274–81.
The remodeling transient and the calcium economy. Osteoporos Int. 2008 Jul;19(7):1001–9.
Molecular aspects of osteopathy in type 1 Gaucher disease: correlation between genetics and bone density. Rheumatol Int. 2008 Jul;28(9):873–7.
Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008 Jul;3(4):1144–51.
3-year follow-up of 215 fracture patients from a prospective and consecutive osteoporosis screening program. Fracture patients care! Acta Orthop. 2008 Jun;79(3):404–9.
Fracture risk and bone mineral density in Turner syndrome. Rev Endocr Metab Disord. 2008 Jun;9(2):145–51. Review.
Mineral metabolism and bone abnormalities in children with chronic renal failure. Rev Endocr Metab Disord. 2008 Jun;9(2):131–7. Review.
Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone. Arch Biochem Biophys. 2008 May 15;473(2):218–24. Review.
Insulin resistance, renal injury, renal 1-alpha hydroxylase, and bone homeostasis in aged obese rats. Arch Med Res. 2008 May;39(4):380–7.
Effects of raloxifene therapy on circulating osteoprotegerin and RANK ligand levels in post-menopausal osteoporosis. J Endocrinol Invest. 2008 May;31(5):416–21.
Generalized metabolic bone disease in Neurofibromatosis type I. Mol Genet Metab. 2008 May;94(1):105–11.
Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study. Osteoporos Int. 2008 May;19(5):673–9.
Healthy children with frequent fractures: how much evaluation is needed? Pediatrics. 2008 May;121(5):890–7.
Pakistani immigrant children and adults in Denmark have severely low vitamin D status. Eur J Clin Nutr. 2008 May;62(5):625–34.
Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone. 2008 May;42(5):996–1003.
Sickle cell bone disease: response to vitamin D and calcium. Am J Hematol. 2008 Apr;83(4):271–4.
The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol. 2008 Mar–Apr;26(2):295–304.
Hypercalcemia in malignancies of the female genital tract. Harefuah. 2008 Mar;147(3):229–34, 277. In Hebrew.
Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med. 2008 Feb 5;148(3):197–213.
Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis). Nefrologia. 2008;28 Suppl 3:67–78. In Spanish.
Association analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves' disease. Acta Biochim Pol. 2008;55(2):371–80.
Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res. 2007 Dec;22 Suppl 2:V50–4. Review.
Vitamin D receptor agonists in the treatment of autoimmune diseases: selective targeting of myeloid but not plasmacytoid dendritic cells. J Bone Miner Res. 2007 Dec;22 Suppl 2:V69–73. Review.
Vitamin D and its implications for musculoskeletal health in women: An update. Maturitas. 2007 Oct 20;58(2):117–37. Review.
Seasonal changes in vitamin D status and bone turnover in healthy Irish postmenopausal women. Int J Vitam Nutr Res. 2007 Sep;77(5):320–5.
Correlation of plain radiographic indices of the hip with quantitative bone mineral density. Osteoporos Int. 2007 Aug;18(8):1119–26.
Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1–235. Review.
What is new in vitamin D: 2006–2007. Curr Opin Rheumatol. 2007 Jul;19(4):383–8.
Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures. Ann Clin Lab Sci. 2007 Summer;37(3):222–32.
Vitamin D and living in northern latitudes—an endemic risk area for vitamin D deficiency. Int J Circumpolar Health. 2008 Jun;67(2–3):164–78. Review.
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007 Jun;85(6):1586–91.
Vitamin d and rehabilitation: improving functional outcomes. Nutr Clin Pract. 2007 Jun;22(3):297–304. Review.
The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement. Bone. 2007 Apr;40(4):1041–7.
Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):134–44. Review.
Osteomalacia and secondary hyperparathyroidism after kidney transplantation: Relationship to vitamin D deficiency. Am J Med Sci. 2007 Jan;333(1):58–62.
Effects of parathyroidectomy on bone remodeling markers and vitamin D status in patients with chronic kidney disease-mineral and bone disorder. Int Urol Nephrol. 2007;39(4):1251–6.
Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging. 2007;24(12):1017–29. Review.
Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol. 2006 Oct;66(4):247–55.
Antiepileptic drugs and bone metabolism. Nutr Metab (Lond). 2006 Sep 6;3(1):36.
Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 2006 Sep;92(1):65–79. Review.
Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr. 2006 Sep;84(3):602–9.
Knee pain, knee osteoarthritis, and the risk of fracture. Arthritis Rheum. 2006 Aug 15;55(4):610–5.
Chronic contamination with 137Cesium affects Vitamin D3 metabolism in rats. Toxicology. 2006 Aug 1;225(1):75–80.
Recent studies on vitamin D metabolizing enzymes. Clin Calcium. 2006 Jul;16(7):1129–35. Review.
Vitamin D status of 51–75-year-old Irish women: its determinants and impact on biochemical indices of bone turnover. Public Health Nutr. 2006 Apr;9(2):225–33.
Osteoblast dysfunction in male idiopathic osteoporosis. Calcif Tissue Int. 2006 Feb;78(2):90–7.
Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006 Jan;69(1):33–43. Review.
Recent advances in the genetics of osteoporosis. J Musculoskelet Neuronal Interact. 2006 Jan–Mar;6(1):27–35. Review.
Epilepsy-related injuries. Epilepsia. 2006;47 Suppl 1:79–86. Review.
25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int. 2005 Oct;68(4):1840–8.
A Randomized Controlled Trial of Vitamin D3 Supplementation in African American Women. Arch Intern Med. 2005 Jul 25;165:1618–1623.
Vitamin-D receptor (VDR) gene (Fok-I, Taq-I and Apa-I) polymorphisms in healthy individuals from north Indian population. Asian Pac J Cancer Prev. 2005 Apr–Jun;6(2):147–52.
Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection. J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):426–31.
1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res. 2005 Feb;20(2):305–17.
Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr. 2004 Dec;80(6):1645–9.
Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004 Sep 1;338(2):143–56. Review.
Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. Am J Clin Nutr. 2004 Jul;80(1):108–13.
Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Osteoporos Int. 2004 Jun;15(6):447–51.
Positive association between 25-hydroxy vitamin d levels and bone mineral density: a population-based study of younger and older adults. Am J Med. Volume 116, Issue 9, Pages 634–639 (1 May 2004).
Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol. 2004 May;89–90(1–5):611–4. Review.
Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short-term growth or bone turnover? Pediatr Pulmonol. 2003 Nov;36(5):399–404.
2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. J Biol Chem. 2003 Aug 22;278(34):31756–65.
Vitamin D supplementation to healthy children does not affect serum osteocalcin or markers of type I collagen turnover. Acta Paediatr. 2003 Jul;92(7):797–801.
Osteopenia in HIV-infected women prior to highly active antiretroviral therapy. J Infect. 2003 May;46(4):221–7.
Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest. 2003 Apr;33(4):323–31.
Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus. Rheumatol Int. 2001 Nov;21(3):97–102.
Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7498–503.
Disorders of bone metabolism in gastrointestinal and hepatic diseases. Ned Tijdschr Geneeskd. 2000 Mar 4;144(10):462–7. Review in Dutch.
Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor. J Cell Biochem. 1999 Dec 1;75(3):462–80.
The renal function of 25-hydroxyvitamin D3-1alpha-hydroxylase. Mol Cell Endocrinol. 1999 May 25;151(1–2):213–20. Review.
Osteoporosis in adult patients with celiac disease. Bone. 1999 Mar;24(3):249–55.
The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol. 1997 Sep;154 Suppl:S57–73. Review.
Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Endocrinology. 1996 May;137(5):2001–11.
Vitamin D deficiency in veterans with chronic spinal cord injury. Metabolism. 1995 Dec;44(12):1612–6.
Receptor mediated genomic action of the 1,25(OH)2D3 hormone: expression of the human vitamin D receptor in E. coli. J Steroid Biochem Mol Biol. 1995 Jun;53(1–6):583–94.
Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders and total parenteral nutrition. Curr Opin Rheumatol. 1995 May;7(3):249–54. Review.
Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. 1995 Mar;61(3 Suppl):638S–645S. Review.
Metabolic bone disease in black teenagers with genu valgum or varum without radiologic rickets: a bone histomorphometric study. J Bone Miner Res. 1994 Apr;9(4):479–86.
Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. Miner Electrolyte Metab. 1993;19(2):78–85.
Oral manifestations of metabolic bone disease: vitamin D and osteoporosis. Compendium. 1990 Oct;11(10):612, 614–8. Review.
Reduced deposition of aluminium in trabecular bone of uraemic rats treated with dihydroxylated vitamin D metabolites. Nephrol Dial Transplant. 1989;4(11):957–65.
The influence of 1 alpha,25- and 24(R),25-dihydroxyvitamin D3 on bone constituents during early mineralization in the rat. Bone Miner. 1986 Oct;1(5):383–96.
The effect of vitamin D on bone in vivo. Endocrinology. 1986 Jun;118(6):2217–24.
Deficiency rickets in an adolescent girl. Arch Fr Pediatr. 1985 Jun–Jul;42(6):443–5.
The effects of long-term anticonvulsant drug therapy on vitamin D metabolites and mineral homeostasis in pregnant epileptic women and their newborns. Ann Chir Gynaecol Suppl. 1985;197:37–41.
Vitamin D metabolism and chronic liver disease. Ann Clin Lab Sci. 1984 May–Jun;14(3):189–97. Review.
Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis. J Clin Endocrinol Metab. 1982 May;54(5):1039–44.
Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease. Q J Med. 1982;51(201):89–103.
Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981. J R Coll Physicians Lond. 1981 Oct;15(4):205–9, 212–7.
Observations on the vitamin D state of pregnant Asian women in London. Br J Obstet Gynaecol. 1981 Jan;88(1):18–26.
Recent advances on vitamin D. Diabete Metab. 1980 Jun;6(2):159–68. Review in French.
Vitamin D deficiency and bone disease in gastrointestinal disorders. Arch Intern Med. 1978 May 15;138 Spec No:886–8.
Vitamin D metabolites and bone mineralization in man. J Clin Endocrinol Metab. 1978 Feb;46(2):284–94.
25-hydroxy-vitamin D, diet and sunlight exposure in patients admitted to a geriatric unit. Gerontology. 1978;24(2):117–22.
Advances in vitamin D metabolism as they pertain to chronic renal disease. Am J Clin Nutr. 1976 Nov;29(11):1283–99.
Metabolism of vitamin D: current status. Am J Clin Nutr. 1976 Nov;29(11):1258–70.
Vitamin D: the discovery of its metabolites and their therapeutic applications. Pediatrics. 1976 May;57(5):729–41. Review.
Studies of vitamin D deficiency in man. Q J Med. 1975 Oct;44(176):575–89.
Osteoporosis and osteomalacia. Schweiz Med Wochenschr. 1975 Apr 12;105(15):466–70.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.